Trade Mark Journal No.2026/046 13 November 2026
UK00004451572 27 September 2026 (5,42)
- Class 5
- Injectable pharmaceuticals; Pharmaceuticals; Pharmaceutical drugs; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations for use in oncology; Pharmaceutical products for the treatment of bone diseases; Dermatological pharmaceutical substances; Dermatological pharmaceutical products; Antibacterial pharmaceuticals; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the prevention of autoimmune diseases; Immunomodulators; Pharmaceutical preparations for treating rheumatological diseases; Pharmaceutical agents for epidermis; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Antitumor drugs; Pharmaceutical preparations for the treatment of tumours; Antineoplastic drugs; Pharmaceutical preparations and substances with anti-inflammatory properties; Anti-cancer drugs; Pharmaceutical preparations for the treatment of digestive diseases; Pharmaceutical preparations for treating arthritis; Pharmaceutical compositions; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of Musculo-skeletal disorders; Pharmaceutical preparations and substances; Pharmaceutical preparations for the treatment of cancer; Regulatory proteins for medical use.
- Class 42
- Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Testing of pharmaceuticals; Pharmaceutical drug development services; Research and development of vaccines and medicines; Research of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Biotechnology testing; Laboratory services relating to the production of monoclonal antibodies; Conducting clinical trials for pharmaceutical products.
Plenty Biologics Limited